The trial included 32 patients with operable esophageal or gastroesophageal junction cancer, who received nivolumab either alone or in combination with relatlimab prior to and during their ...

Invited discussant Elizabeth Plimack, MD, MS, deputy director of the Fox Chase Cancer Center at Temple Health in Philadelphia, said that the absolute DFS and OS benefits seen with nivolumab in ...

Opdivo (nivolumab) is a prescription drug used ... Opdivo can be prescribed to treat certain kinds of esophageal cancer and gastric (stomach) cancer that have spread to other areas of the body.

During a live event, Sumanta K. Pal, MD, discusses the efficacy and safety findings from the CheckMate 274 trial of adjuvant ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

The primary endpoint was progression-free survival (PFS; nivolumab/ipilimumab vs chemotherapy ... repair deficient metastatic colorectal cancer,” said Dana Walker, MD, MSCE, vice president ...

The Harrison resident, diagnosed with esophageal cancer in 2021, worried about looking his best for his son’s wedding. “I was all worked up,” said Hines, 60, retired after 30 years with the ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

A total of 495 patients were randomized to receive either “subcutaneous nivolumab ... lung cancer; head and neck squamous cell carcinoma; colorectal cancer, hepatocellular carcinoma, esophageal ...